封面
市场调查报告书
商品编码
1136941

组织银行市场:各产品类型,各地区,规模,占有率,展望,机会分析,2022年~2030年

Tissue Banking Market, by Product, by Tissue Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

市场动态

对移植物的手术需求增加、髋关节置换手术中的骨移植物需求、股骨头移植物需求以及烧伤患者发病率的增加是推动组织库市场增长的主要因素。

本调查的主要特征

  • 本报告提供以2021年为基准年的预测期间(2022-2030 年)之全球组织银行市场的市场规模和復合年增长率(CAGR %)相关的详细分析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球组织银行市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球组织银行市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球组织银行市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称的说明

第2章 市场展望

  • 报告内容
    • 市场定义和范围
  • 摘要整理
    • 市场概述:各产品
    • 市场概述:组织各类型
    • 市场概述:各地区
  • 连贯机遇地图(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的发展情形
  • 技术的进步
  • 供应链分析
  • 法规情形
  • PEST分析

第4章 组织银行的全球市场:冠状病毒(COVID-19)流行的影响

  • 整体影响
  • 政府的配合措施
  • COVID-19对市场的影响

第5章 组织银行的全球市场:各产品,2017年~2030年

  • 培养基与消耗品
  • 设备
  • 冻结保存设备
  • 品管设备
  • 解冻设备
  • 其他

第6章 组织银行的全球市场:组织各类型,2017年~2030年

  • 脑和脊髓
  • 角膜
  • 心臟瓣膜
  • 其他

第7章 组织银行的全球市场:各地区,2017年~2030年

  • 北美
  • 美国
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他的南美地区
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东地区
  • GCC
  • 以色列
  • 其他的中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第8章 竞争情形

  • 热图分析
  • 企业简介
    • AbD Serotec
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

第9章 章节

  • 参考文献
  • 调查手法
简介目录
Product Code: CMI2600

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility. A tissue bank is an establishment that collects and recovers human cadaver tissue for the purposes of medical research, education and allograft transplantation. A tissue bank may also refer to a location where biomedical tissue is stored under cryogenic conditions and is generally used in a more clinical sense. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand of allografts resulted in the establishment of in house tissue banking activity at major burns center(s). Large numbers of skin banks were opened near major institutions handling burns patients in the U.S. There are more than fifty operational skin and tissue banks in the U.S. at present. Skin banking is a process in which tissue is removed from a donor's body, tested for suitability as a graft material, packaged and stored and finally reused as a graft.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to the WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study:

  • This report provides an in-depth analysis of the global tissue banking market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue banking market

Detailed Segmentation:

  • Global Tissue Banking Market, By Product:
    • Media and Consumables
    • Equipment
      • Cryopreservation Equipment
      • Quality Control Equipment
      • Thawing equipment
      • Others
  • Global Tissue Banking Market, By Tissue Type:
    • Bone
    • Brain & Spinal Cord
    • Cornea
    • Heart Valves
    • Skin
    • Others
  • Global Tissue Banking Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • AbD Serotec*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Tissue Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Supply Chain Analysis
  • Regulatory Landscape
  • PEST Analysis

4. Global Tissue Banking Market - Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Tissue Banking Market, By Product, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Media and Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cryopreservation Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Quality Control Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Thawing Equipment
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tissue Banking Market, By Tissue Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Bone
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Brain and Spinal Cord
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Cornea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Heart Valves
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tissue Banking Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Tissue Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • AbD Serotec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AMS Biotechnology Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioLife Solutions, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Beckman Coulter, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioCision LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • BioStorage Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Custom BioGenic Systems
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Eppendorf AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • EMD Millipore Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Fisher BioServices, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Genzyme Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Hamilton Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Merck KGaA
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • PHC Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact